−£144k
Not reported the period beforeActive15567990Private limited companyAltrincham
ETERNA BIOLOGICS LTD
Significant control: Tatjana Sauka Spengler (significant control), Daniel Mark Fountain (significant control) and 1 more
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Eterna Biologics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Eterna Biologics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ETERNA BIOLOGICS LTD is an active private limited company (company number 15567990) incorporated on 16 March 2024, registered in Altrincham. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2025, showing net assets of −£144k and cash of £48k, with 3 employees on average.
Peer position · net assets
By net assets it sits in the bottom quarter of 138 comparable companies in Manchester (median £436, upper quartile £124k).
02
Ownership and control
- Tatjana Sauka Spengler
- has significant influence or control
- Dr. Daniel Mark Fountain
- has significant influence or control
- Dr Muhammad Hanifi
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 16 March 20242 yrs ago
- Next accounts due
- 31 December 2026in 67 days
- Confirmation statement due
- 30 March 2027in 156 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£48k
Not reported the period beforeNot reported
3
vs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | −£144k | £48k | — | £38k | — | — | 3 |
| 15 March 2024 | — | — | — | — | — | — | 0 |
Current ratio1.48Current assets ÷ creditors within one year
Cash per employee£16kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-143,520 at 31 March 2025
- Incorporated two to five years agoIncorporated 16 March 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 156 days
- Next accounts duein 67 days
- Accounts period endNet liabilities £144k · small accounts
- Incorporated
- Accounts period end
08
Similar companies in Manchester
- REDDINGTON VENTURES LTD.Manchester · inc. Mar 2024
- BIOSECURE ID LIMITEDMacclesfield · inc. Mar 2024
- CELL SQUARED LIMITEDChinley · inc. Apr 2024
- IMMUNOKEY LTDWilmslow · inc. Feb 2024
- QUODRIA LTDWarrington · inc. Apr 2024
- MOLECULAR GLUE LABS LTDAltrincham · inc. Feb 2024
All companies incorporated on 16 March 2024 · in Mar 2024.
09
Reminders for ETERNA BIOLOGICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.